The global biopharmaceuticals market is experiencing substantial growth, supported by increasing demand for advanced biological therapies, technological advancements in biotechnology, and the expanding application of biologics across various therapeutic areas. The market was valued at US$ 485.75 billion in 2025 and is projected to reach US$ 1,549.67 billion by 2034. It is anticipated to...

The lyophilization services for biopharmaceuticals market is expanding as pharmaceutical and biotechnology companies increasingly outsource specialized manufacturing and drug development activities. Lyophilization, also known as freeze-drying, helps improve the stability, shelf life, and storage characteristics of temperature-sensitive biopharmaceutical products. The growing development of...

Single-Use Technology for Biopharmaceuticals Market: How Disposable Bioprocessing Is Reshaping Biomanufacturing Single-use technology for biopharmaceuticals refers to disposable bioprocessing equipment, including bioreactors, bags, filters, tubing and connectors, that is used for one batch or a limited number of runs. Polaris Market Research values the single-use technology for...

The United States Lyophilization Services for Biopharmaceuticals Market is driven by the strong presence of pharmaceutical and biotechnology companies, rising biologics production, and increasing reliance on contract development and manufacturing organizations. The Lyophilization Services for Biopharmaceuticals Market is projected to grow from US$2,051.41 million in 2022 to US$3,586.55 million...

Antiviral Drugs Market: Advancing Global Healthcare Through Innovative Antiviral Therapies Antiviral Drugs Market Snapshot The Antiviral Drugs Market is witnessing stable growth as the global burden of viral infections continues to drive demand for effective therapeutic solutions. According to M2Square Consultancy, the global Antiviral Drugs Market was valued...

The Biopharmaceuticals Contract Manufacturing Market is expanding as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations. The market was valued at USD 44.7 billion in 2025 and is projected to grow from USD 50.0 billion in 2026 to USD 100.8 billion by 2033, registering a CAGR of...